Industries > Pharma > Vaccines Sales Market Report 2020-2030

Vaccines Sales Market Report 2020-2030

Forecasts by Disease Type (Viral Diseases, Bacterial Diseases), Viral Diseases (Hepatitis, Influenza, Human Papillomavirus, Measles/Mumps/Rubella, Rotavirus, Other Viral Diseases), Bacterial Disease (Pneumococcal Disease, Meningococcal Disease, Diphtheria/Tetanus/Pertussis, Other Bacterial Disease), Type of Vaccines (Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated, Toxoid), Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Other Distribution Channel), Age Group (Paediatrics, Adults, Other Age Groups), Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa), Competitive Landscape PLUS COVID-19 Impact Analysis and Profiles of Leading Vaccines Sales Companies

PUBLISHED: 10 September 2020
PAGES: 602
PRODUCT CODE: PHA0809
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0809 Categories: , Tags: ,

Vaccine Sales Market–our new study reveals trends, R&D progress, and predicted revenues
Where is the Vaccines market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 602 pages report provides 400+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Vaccines Market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), product profiles and commercial developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

To access the data contained in this document please email contactus@visiongain.com

Discover sales predictions for the world market and submarkets

Report Scope

• Disease Type
– Viral Diseases
– Bacterial Diseases

• Viral Diseases
– Hepatitis
– Influenza
– Human Papillomavirus
– Measles/Mumps/Rubella
– Rotavirus
– Other Viral Diseases

• Bacterial Disease
– Pneumococcal Disease
– Meningococcal Disease
– Diphtheria/Tetanus/Pertussis
– Other Bacterial Disease

• Type Vaccines
– Recombinant/Conjugate/Subunit
– Inactivated
– Live Attenuated
– Toxoid

• Distribution Channel
– Hospital & Retail Pharmacies
– Government Suppliers
– Other Distribution Channel

• Age Group
– Paediatrics
– Adults
– Other Age Groups

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 19 leading national markets:

• North America
– U.S.
– Canada

• Europe
– Germany
– UK
– France
– Italy
– Russia
– Rest of Europe

• Asia Pacific
– Japan
– China
– India
– South Korea
– Australia
– Rest of Asia Pacific

• Middle East and Africa
– Saudi Arabia
– South Africa
– Iran
– UAE
– Rest of Middle East and Africa

• Latin America
– Brazil
– Mexico
– Nigeria
– Rest of Latin America

Vaccines Sales Market Report 2020-2030

Brazil Vaccine Sales Market Outlook
The Brazilian human vaccines market is the largest in Latin America. Brazil has been an important developing market, especially in its region. However current economic and political instabilities have made is a little bit weary. Nonetheless, Brazil still possesses the characteristic of an emerging country to have a growing middle class who are determined to get better access to healthcare. The progress of healthcare has increased the life expectancy of people in Brazil, leading to a growing elderly population that demand vaccines.

Brazil vaccines market was valued at US$ xx billion in 2019 and is projected to reach at a market value of US$ xx billion by 2030. Brazil market is expected to grow at a CAGR of xx% during the forecast period 2020-2030. The market is estimated to grow at a CAGR of xx% in the first half period 2020-2025 and is projected to grow at CAGR of xx% in the other half period 2025-2030.

This report forecasts that the global vaccine market is expected to grow steadily during the forecast period from 2020 to 2030. This will be driven by an ageing population and an increase in the incidence of chronic diseases that increase the risk of infection in human immune systems. Furthermore, as your economies become prosperous, your spending on health care increases, the demand from emerging markets will increase. The travel industry will also help sustain growth on the vaccine market, with higher revenues from the adult vaccine subservice resulting from increased awareness about vaccinating benefits for a country’s workforce.

As treatment options become more innovative, businesses will strive to remove the cold chain from their supply logistics, cut costs, and make it easier to supplies vaccines in different climates and regions, the future of the human vaccine market looks very promising. Several innovative vaccines are on the market in the pipeline. These vaccines are progressive improvements in vaccine efficacy, coverage through more disease strains and viable therapy against previously untreatable illnesses. This will help address a larger group of people with different health requirements, thereby increasing access and coverage of vaccinations.

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general. The growth will highlight the importance of vaccines to the global population’s health and the potential advantages for the global economy between 2020 and 2030.

Companies Profiled in the Report
• AstraZeneca
• Bavarian Nordic
• Bayer
• BiondVax
• Bristol-Myers Squibb
• Eli Lilly
• Emergent BioSolutionsInc
• Fresenius
• GlaxoSmithKline (GSK)
• Johnson & Johnson
• Merck & Co.
• Pfizer
• Roche
• Sanofi Pasteur
• Takeda

The Vaccines Market Pipeline Analysis
• A SWOT and STEP analysis of the global vaccines market
• Key Questions Answered by this Report:
• What is the current size of the overall global human vaccines market? How much will this market be worth from 2020 to 2030?
• What are the main drivers and restraints that will shape the overall vaccines market over the next ten years?
• What are the main segments within the overall human vaccines market? How much will each of these segments be worth for the period 2020 to 2030? How will the composition of the market change during that time, and why?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the world vaccines? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2030?
• How will political and regulatory forces influence regional markets?
• How will market shares of the leading national markets change by 2030, and which geographical region will lead the market in 2030?
• Who are the leading companies and what are their activities, results, developments, and prospects?
• What are the leading vaccines? What are their revenues and latest developments?
• What are some of the most prominent human vaccines currently in development?
• What are the main trends that will affect the world vaccines market between 2020 and 2030?
• What are the main strengths, weaknesses, opportunities, and threats for the market?
• What are the social, technological, economic, and political influences that will shape that industry over the next ten years?
• How will the global vaccines market evolve over the forecasted period, 2020 to 2030?
• How will the market shares for each checkpoint inhibitor anti-cancer treatment submarket develop from 2020 to 2030?
• Which therapies can succeed and what revenues could they generate to 2030?
• What will be the main commercial drivers for the market from 2020 to 2030?
• How will market shares of prominent national markets change from 2020, and which countries will lead the market in 2030, achieving highest revenues and fastest growth?
• How will that industry evolve between 2020 and 2030, especially in R&D?

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Vaccines Sales Market. You find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Vaccines Sales Market Analysis : Forecasts by Disease Type (Viral Diseases, Bacterial Diseases), Viral Diseases (Hepatitis, Influenza, Human Papillomavirus, Measles/Mumps/Rubella, Rotavirus, Other Viral Diseases), Bacterial Disease (Pneumococcal Disease, Meningococcal Disease, Diphtheria/Tetanus/Pertussis, Other Bacterial Disease), Type of Vaccines (Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated, Toxoid), Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Other Distribution Channel), Age Group (Paediatrics, Adults, Other Age Groups), Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa), Competitive Landscape PLUS COVID-19 Impact Analysis and Profiles of Leading Vaccines Sales Companies. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Vaccines Sales Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Vaccines Sales Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Influenza Vaccines Market Report 2020-2030

For the companies operating in the global influenza vaccines market, there is an immense opportunity from emerging economies across the globe.

30 September 2020

READ

Visiongain Publishes Next-Generation Pharmaceutical Temperature Management Solutions Market Report 2020-2030

Maintaining the quality and safety of the product in the supply chain has always been a high priority for pharmaceutical companies. New market dynamics including an evolving product line, more stringent regulations, geographically connected supply chains, rising risk, and extreme cost pressure have raised stakes significantly.

28 September 2020

READ

Visiongain Publishes OTC Drugs & Dietary Supplements Market Report 2020-2030

The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.

23 September 2020

READ

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

READ

Categories

Category